These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Opioid pharmacotherapy: Treatment, regimes, constructions and control. Neale J Int J Drug Policy; 2013 Nov; 24(6):e1-5. PubMed ID: 24075399 [No Abstract] [Full Text] [Related]
46. Putting Parity into Practice - Integrating Opioid-Use Disorder Treatment into the Hospital Setting. Fanucchi L; Lofwall MR N Engl J Med; 2016 Sep; 375(9):811-3. PubMed ID: 27579631 [No Abstract] [Full Text] [Related]
47. Standing Against Addiction. Berlin J Tex Med; 2016 Sep; 112(9):49-54. PubMed ID: 27622893 [TBL] [Abstract][Full Text] [Related]
48. Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential. Fox L; Nelson LS CNS Drugs; 2019 Dec; 33(12):1147-1154. PubMed ID: 31552608 [TBL] [Abstract][Full Text] [Related]
49. Rational Perioperative Opioid Management in the Era of the Opioid Crisis: Comment. Shishido S; Bowdle A Anesthesiology; 2020 Oct; 133(4):941-942. PubMed ID: 32773691 [No Abstract] [Full Text] [Related]
50. Rational Perioperative Opioid Management in the Era of the Opioid Crisis: Comment. Gupta D; Chakrabortty S Anesthesiology; 2020 Oct; 133(4):940-941. PubMed ID: 32773692 [No Abstract] [Full Text] [Related]
51. Rational Perioperative Opioid Management in the Era of the Opioid Crisis: Reply. Kharasch ED; Avram MJ; Clark JD Anesthesiology; 2020 Oct; 133(4):942-943. PubMed ID: 32773694 [No Abstract] [Full Text] [Related]
52. Opioid misuse epidemic: Addressing opioid prescribing and organization initiatives for holistic, safe and compassionate care. Naegle M; ; Mitchell AM; ; Flinter M; ; Dunphy L; ; Vanhook P; ; Delaney KR; Nurs Outlook; 2017; 65(4):477-479. PubMed ID: 28821312 [No Abstract] [Full Text] [Related]
53. Clinical and Professional Aspects of Opioid Prescribing for Pain Physicians. Kaye AD Pain Physician; 2017 Feb; 20(2S):S1-S2. PubMed ID: 28226331 [No Abstract] [Full Text] [Related]
54. General pharmacology of long-acting, extended-release, and sustained-release opioids for the treatment of chronic nonmalignant pain. Davis MP; Gamier P; Sloan PA J Opioid Manag; 2015; Suppl():11-20. PubMed ID: 25539289 [No Abstract] [Full Text] [Related]
55. Buprenorphine implants (Probuphine) for opioid dependence. Med Lett Drugs Ther; 2016 Jul; 58(1499):94-5. PubMed ID: 27403784 [No Abstract] [Full Text] [Related]
56. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine. Moody DE Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):675-97. PubMed ID: 23537174 [TBL] [Abstract][Full Text] [Related]
57. Buprenorphine for opioid dependence. Milne M; Crouch BI; Caravati EM J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216 [TBL] [Abstract][Full Text] [Related]
58. New drug buprenorphine can treat patients addicted to heroin or prescription pain medications. Clark HW W V Med J; 2003; 99(1):42. PubMed ID: 12762216 [No Abstract] [Full Text] [Related]
59. Transforming Management of Opioid Use Disorder with Universal Treatment. Gupta R; Levine RL; Cepeda JA; Holtgrave DR N Engl J Med; 2022 Oct; 387(15):1341-1344. PubMed ID: 36129991 [No Abstract] [Full Text] [Related]
60. Improving Outcomes for People With Injection Drug-related Endocarditis: Are Medications for Opioid Use Disorder Enough? Kimmel SD; Del Rio C J Addict Med; 2020; 14(4):280-0. PubMed ID: 31634203 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]